FR2895679B1 - Stabilisation de testosterone au sein de dispositifs transdermiques - Google Patents

Stabilisation de testosterone au sein de dispositifs transdermiques

Info

Publication number
FR2895679B1
FR2895679B1 FR0513435A FR0513435A FR2895679B1 FR 2895679 B1 FR2895679 B1 FR 2895679B1 FR 0513435 A FR0513435 A FR 0513435A FR 0513435 A FR0513435 A FR 0513435A FR 2895679 B1 FR2895679 B1 FR 2895679B1
Authority
FR
France
Prior art keywords
testosterone
stabilization
transdermal devices
transdermal
devices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0513435A
Other languages
English (en)
Other versions
FR2895679A1 (fr
Inventor
Michel Sournac
Joel Bougaret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0513435A priority Critical patent/FR2895679B1/fr
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to US12/086,964 priority patent/US20080317859A1/en
Priority to BRPI0620839-8A priority patent/BRPI0620839A2/pt
Priority to CA002635422A priority patent/CA2635422A1/fr
Priority to PCT/FR2006/002873 priority patent/WO2007074239A1/fr
Priority to CNA2006800495563A priority patent/CN101351180A/zh
Priority to JP2008548013A priority patent/JP2009522243A/ja
Priority to NZ568658A priority patent/NZ568658A/en
Priority to UAA200809847A priority patent/UA97354C2/ru
Priority to AU2006329751A priority patent/AU2006329751A1/en
Priority to RU2008131064/15A priority patent/RU2419436C2/ru
Priority to KR1020087016196A priority patent/KR20080081166A/ko
Priority to EP06847141A priority patent/EP1965749A1/fr
Publication of FR2895679A1 publication Critical patent/FR2895679A1/fr
Priority to MA30982A priority patent/MA30015B1/fr
Priority to ZA200805157A priority patent/ZA200805157B/xx
Priority to IL192406A priority patent/IL192406A0/en
Priority to TNP2008000286A priority patent/TNSN08286A1/fr
Priority to NO20083306A priority patent/NO20083306L/no
Publication of FR2895679B1 publication Critical patent/FR2895679B1/fr
Application granted granted Critical
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
FR0513435A 2005-12-29 2005-12-29 Stabilisation de testosterone au sein de dispositifs transdermiques Expired - Fee Related FR2895679B1 (fr)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FR0513435A FR2895679B1 (fr) 2005-12-29 2005-12-29 Stabilisation de testosterone au sein de dispositifs transdermiques
EP06847141A EP1965749A1 (fr) 2005-12-29 2006-12-26 Stabilisation de testosterone au sein de dispositifs transdermiques
BRPI0620839-8A BRPI0620839A2 (pt) 2005-12-29 2006-12-26 estabilização de testosterona no seio de dispositivos transdérmicos
PCT/FR2006/002873 WO2007074239A1 (fr) 2005-12-29 2006-12-26 Stabilisation de testosterone au sein de dispositifs transdermiques.
CNA2006800495563A CN101351180A (zh) 2005-12-29 2006-12-26 透皮装置内睾酮的稳定化
JP2008548013A JP2009522243A (ja) 2005-12-29 2006-12-26 経皮デバイス中のテストステロンの安定化
NZ568658A NZ568658A (en) 2005-12-29 2006-12-26 Testosterone stabilisation in transdermal devices
UAA200809847A UA97354C2 (ru) 2005-12-29 2006-12-26 Стабилизация тестостерона в устройствах чрескожного воздействия
KR1020087016196A KR20080081166A (ko) 2005-12-29 2006-12-26 경피 장치에서의 테스토스테론의 안정화
RU2008131064/15A RU2419436C2 (ru) 2005-12-29 2006-12-26 Стабилизация тестостерона в устройствах чрескожного действия
US12/086,964 US20080317859A1 (en) 2005-12-29 2006-12-26 Stabilization of Testosterone Within Transdermal Devices
CA002635422A CA2635422A1 (fr) 2005-12-29 2006-12-26 Stabilisation de testosterone au sein de dispositifs transdermiques.
AU2006329751A AU2006329751A1 (en) 2005-12-29 2006-12-26 Testosterone stabilisation in transdermal devices
MA30982A MA30015B1 (fr) 2005-12-29 2008-06-02 Stabilisation de testosterone au sein de dispositifs transdermiques
ZA200805157A ZA200805157B (en) 2005-12-29 2008-06-12 Testosterone stabilisation in transdermal devices
IL192406A IL192406A0 (en) 2005-12-29 2008-06-23 Testosterone stabilisation in transdermal devices
TNP2008000286A TNSN08286A1 (fr) 2005-12-29 2008-06-27 Stabilisation de testosterone au sein de dispositifs transdermiques
NO20083306A NO20083306L (no) 2005-12-29 2008-07-25 Testosteronstabilisering i transdermale anordninger

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0513435A FR2895679B1 (fr) 2005-12-29 2005-12-29 Stabilisation de testosterone au sein de dispositifs transdermiques

Publications (2)

Publication Number Publication Date
FR2895679A1 FR2895679A1 (fr) 2007-07-06
FR2895679B1 true FR2895679B1 (fr) 2012-06-08

Family

ID=37075280

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0513435A Expired - Fee Related FR2895679B1 (fr) 2005-12-29 2005-12-29 Stabilisation de testosterone au sein de dispositifs transdermiques

Country Status (18)

Country Link
US (1) US20080317859A1 (fr)
EP (1) EP1965749A1 (fr)
JP (1) JP2009522243A (fr)
KR (1) KR20080081166A (fr)
CN (1) CN101351180A (fr)
AU (1) AU2006329751A1 (fr)
BR (1) BRPI0620839A2 (fr)
CA (1) CA2635422A1 (fr)
FR (1) FR2895679B1 (fr)
IL (1) IL192406A0 (fr)
MA (1) MA30015B1 (fr)
NO (1) NO20083306L (fr)
NZ (1) NZ568658A (fr)
RU (1) RU2419436C2 (fr)
TN (1) TNSN08286A1 (fr)
UA (1) UA97354C2 (fr)
WO (1) WO2007074239A1 (fr)
ZA (1) ZA200805157B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
WO2016033549A2 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Compositions de (17-ss)-3-oxoandrost-4-èn-17-yl tridécanoate et leurs procédés de préparation et d'utilisation
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
WO1998024393A1 (fr) * 1996-12-03 1998-06-11 Minnesota Mining And Manufacturing Company Distributeurs de timbres transdermiques/transmuqueux
GB9720470D0 (en) * 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19913761B4 (de) * 1999-03-26 2005-02-10 Lts Lohmann Therapie-Systeme Ag Trocknungsvorrichtung und Verfahren zu ihrer Herstellung sowie ihre Verwendung
FR2793689B1 (fr) * 1999-05-19 2001-08-24 Pf Medicament Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
DE19925613A1 (de) * 1999-06-04 2000-12-07 Lohmann Therapie Syst Lts Verbundlaminat und Verfahren zu seiner Herstellung
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems

Also Published As

Publication number Publication date
CA2635422A1 (fr) 2007-07-05
RU2419436C2 (ru) 2011-05-27
IL192406A0 (en) 2008-12-29
AU2006329751A1 (en) 2007-07-05
MA30015B1 (fr) 2008-12-01
KR20080081166A (ko) 2008-09-08
WO2007074239A1 (fr) 2007-07-05
FR2895679A1 (fr) 2007-07-06
UA97354C2 (ru) 2012-02-10
RU2008131064A (ru) 2010-02-10
JP2009522243A (ja) 2009-06-11
ZA200805157B (en) 2009-06-24
CN101351180A (zh) 2009-01-21
NO20083306L (no) 2008-09-16
TNSN08286A1 (fr) 2009-10-30
EP1965749A1 (fr) 2008-09-10
NZ568658A (en) 2011-10-28
BRPI0620839A2 (pt) 2011-11-29
US20080317859A1 (en) 2008-12-25

Similar Documents

Publication Publication Date Title
DE602006001275D1 (de) Gassack und Gassackeinrichtung
DE602006011234D1 (de) Airbag und Airbagvorrichtung
EP2349020A4 (fr) Dispositifs de mise en tension de câbles d'attache et procédés associés
EP2248159A4 (fr) Structures de dispositifs à semi-conducteurs et procédés s'y rapportant
DE602006005104D1 (de) Luftsack und Luftsackvorrichtung
ATE442876T1 (de) Nadelfreie transdermale transportvorrichtung
DE602006008981D1 (de) Spannungsumsetzungseinrichtung
IL209380A0 (en) Small molecule inhibitors for the treatment or prevention of dengue virus infection
DK1848473T3 (da) Plasmakoncentrationsanordning
DE602006012674D1 (de) Halbleitervorrichtung und dazugehörige Montagestruktur
DE602006002000D1 (de) Gassack und Gassackeinrichtung
DE602006009334D1 (de) Vorhang-Airbagvorrichtung
BRPI0719918A2 (pt) Tratamento para olho seco usando-se testosterona e progestagênio
EP1847521A4 (fr) Derive de bisanthracene et dispositif electroluminescent organique l'utilisant
GB0524961D0 (en) Transdermal administration of active agents for systemic effect
GB0524958D0 (en) Transdermal administration of active agents
EP1963203A4 (fr) Structure d'un dispositif d'emballage avec de l'air
GB0512073D0 (en) Device for use in treatment of varicose veins
GB0722578D0 (en) Methods and compositions for delaying the release of treatment chemicals
EP2032022A4 (fr) Dispositif et procédés de détection d'une ischémie tissulaire évaluée localement
DE602006000563D1 (de) Gassack und Gassackeinrichtung
DE602006012005D1 (de) Druckgerät und wasserdichte Struktur dafür
DK2310001T3 (da) Transdermal estradiol-indretning og -indgivelse
DE602006015605D1 (de) Verpackungsvorrichtung und Puffer
DE502006000713D1 (de) Verriegelungsvorrichtung

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140829